Advanced Signaling Company Inc.

ARIAD to Present at the Oppenheimer 20th Annual Healthcare Conference.(Conference news)
Cancer Weekly; 11/10/2009; 855 words; ...Pharmaceuticals, Inc. (NASDAQ: ARIA...an overview of the Company and its progress...Pharmaceuticals, Inc.). The ARIAD presentation...in patients with advanced sarcomas and is being...with Merck & Co., Inc. ARIAD's second...certain NF-?B cell-signaling activity, which...

Curis to Present at the Oppenheimer 20th Annual Healthcare Conference.(Conference news)
Cancer Weekly; 11/10/2009; 958 words; ...drug development company seeking to develop...see also Curis, Inc.). Dan Passeri...Phase II trial in advanced basal cell carcinoma...colorectal cancer and advanced ovarian cancer...com. About Curis, Inc. Curis is a drug...leveraging its innovative signaling pathway drug ...

AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer.
PR Newswire; 11/9/2009; 991 words; ...AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical...role of PI3K and Akt signaling pathways in renal...described as the most advanced PI3K/Akt pathway...Biopharmaceuticals, Inc. , is AEterna Zentaris...PI3K/Akt/mTOR signaling pathways in ...

To Buy or Not to Buy: 4 Retailers Worth Considering - Investment Ideas
Zacks Investment Research - Investment Ideas; 11/5/2009; 1419 words; ...economic reports are signaling doom and gloom...retail sales advanced for the second...Plays The TJX Companies (TJX) is a...worldwide. The Company operates 882...year. The company recently upped...5 years. TJX Companies is scheduled...of 18%. The company's net profit...of 2%. ...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2331 words; Advanced Biotherapy Inc., of Woodland...disclosed. Axcan Pharma Inc., of Mont-Saint...stability of cell-signaling proteins and affect...to Merck & Co. Inc., of Whitehouse...final terms. The company said it would not...arthritis. The companies said they would...